EDISON, N.J., Feb. 24, 2025 (GLOBE NEWSWIRE) -- Apex Defi Labs Inc., a leader in blockchain-based tokenized securities, proudly announces its strategic partnership with Regiment Securities, LLC (RSLLC ...
Report champions expansion of early access and funding for Canadian Veterans. VANCOUVER, BC, Nov. 17, 2023 /PRNewswire/ - Apex Labs Ltd. (APEX or the Company), a pharmaceutical company transforming ...
-Patent pending uniquely formulated capsule improves stability and bioavailability for psilocybin and other psychedelics -Supports both APEX-52 take home microdose and APEX-90 in-clinic macrodose ...
Authorized to sell psilocybin through Health Canada's Special Access Program. "Receiving this licence is a significant achievement for APEX alongside our tremendous progress actively dosing patients ...
Psychiatrist Dr. Mark Johnston as CMO and senior pharmaceutical commercialization expert Greg Rutherford as CCO accelerates APEX's ability to bring new drugs to market. VANCOUVER, BC, Aug. 10, 2023 ...
VANCOUVER, BC, June 9, 2023 /PRNewswire/ - Apex Labs Ltd. (APEX or the Company), a pharmaceutical company transforming the standard of mental health care with clinically proven psilocybin treatments, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback